As some of you may know, CGD’s Drug Resistance Working Group released a report this summer, providing a comprehensive examination of drug resistance—across different diseases, geographies, and stakeholders. The report highlights alarmingly high rates of drug resistance throughout the world and warns of a growing public health crisis as more and more drugs lose their efficacy.
CGD Policy Blogs
A new research study by Hoare et al in PLoS (ungated) projects that, within ten years after countries attain universal access to antiretroviral treatment for AIDS, one fifth of all patients starting treatment will never have a chance to benefit from the least-expensive and least-toxic treatments, because their initial infection will be a drug resistant strain of HIV.
This week on the Wonkcast, I'm joined by Rachel Nugent, Deputy Director for Global Health here at the Center for Global Development. She is the lead author on a new CGD working group report entitled The Race Against Drug Resistance, which prescribes a global effort to halt and reverse the spread of drug resistant microbes.